Please feel free to visit our booth
and find more about Himalca™
Clinically proven for Eye health and Liver health
Conducted In-vitro, In-vivo study and Human clinical trial
Average MPOD significantly improved after 180 days
ALT decreased 36.7% AST decreased 27% GGT decreased 18.8% After 12 weeks